US Stock MarketDetailed Quotes

Entrada Therapeutics (TRDA)

Watchlist
  • 13.990
  • +0.430+3.17%
Close Apr 17 16:00 ET
  • 14.270
  • +0.280+2.00%
Post 20:01 ET
535.60MMarket Cap-4.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entrada Therapeutics (TRDA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-209.24%-128.51M
-1.89%-32.2M
-16.68%-28.31M
-174.03%-29.49M
-50.90%-38.51M
-129.73%-41.56M
-687.57%-31.61M
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
Net income from continuing operations
-319.04%-143.75M
-3,562.78%-39.16M
-214.52%-44.13M
-178.32%-43.1M
-173.84%-17.35M
1,081.69%65.63M
111.85%1.13M
-139.57%-14.03M
312.25%55.03M
452.05%23.5M
Depreciation and amortization
8.56%4.1M
-10.69%886K
31.27%1.23M
13.63%1.03M
1.28%946K
32.81%3.77M
34.78%992K
12.35%937K
24.66%910K
72.64%934K
Change In working capital
95.96%-4.8M
106.54%2.35M
179.68%10.21M
145.99%8.49M
49.94%-25.85M
-187.19%-118.85M
-1,316.42%-35.92M
79.44%-12.82M
-63.14%-18.47M
-124.95%-51.65M
-Change in receivables
13.88%2.5M
101.76%19K
-100.32%-16K
-98.76%864K
102.28%1.64M
137.39%2.2M
-26.26%-1.08M
495.86%5.07M
2,635.61%69.84M
-1,037.62%-71.64M
-Change in prepaid assets
272.23%7.64M
150.59%1.5M
393.32%3.73M
262.95%4.68M
-184.81%-2.27M
-151.46%-4.44M
-123.75%-2.97M
91.39%-1.27M
-143.88%-2.87M
-38.23%2.68M
-Change in payables and accrued expense
445.90%2.28M
-21.98%653K
555.03%5.67M
414.69%3.19M
-437.44%-7.23M
-113.08%-658K
-90.02%837K
114.60%865K
51.04%-1.01M
-129.00%-1.35M
-Change in other current assets
-15.48%10.88M
-43.37%1.76M
37.53%3.6M
-39.35%2.78M
7.11%2.74M
2,922.54%12.88M
201.26%3.12M
43.47%2.61M
59.77%4.59M
148.29%2.56M
-Change in other current liabilities
8.29%-8.28M
30.33%-1.47M
25.12%-2.34M
-13.32%-2.25M
-22.91%-2.21M
23.93%-9.02M
-350.54%-2.11M
20.98%-3.13M
70.72%-1.99M
7.79%-1.8M
-Change in other working capital
83.45%-19.83M
99.64%-122K
97.53%-419K
99.12%-770K
-203.46%-18.51M
-185.59%-119.81M
-77.73%-33.72M
55.60%-16.97M
-503.22%-87.02M
-91.54%17.9M
Cash from discontinued investing activities
Operating cash flow
-209.24%-128.51M
-1.89%-32.2M
-16.68%-28.31M
-174.03%-29.49M
-50.90%-38.51M
-129.73%-41.56M
-687.57%-31.61M
0.92%-24.27M
213.51%39.83M
-112.55%-25.52M
Investing cash flow
Cash flow from continuing investing activities
520.20%116.81M
-45.43%29.12M
159.22%49.11M
238.61%33.8M
-81.71%4.78M
79.91%-27.8M
180.23%53.37M
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
Net PPE purchase and sale
67.04%-1.04M
132.60%207K
126.76%171K
73.71%-275K
-36.52%-1.14M
43.75%-3.16M
34.94%-635K
55.87%-639K
31.27%-1.05M
49.76%-838K
Net investment purchase and sale
578.28%117.85M
-46.46%28.91M
159.47%48.94M
246.00%34.07M
-78.04%5.93M
81.44%-24.64M
169.74%54M
-3,494.93%-82.29M
79.11%-23.34M
169.59%26.99M
Cash from discontinued investing activities
Investing cash flow
520.20%116.81M
-45.43%29.12M
159.22%49.11M
238.61%33.8M
-81.71%4.78M
79.91%-27.8M
180.23%53.37M
-2,119.08%-82.93M
78.47%-24.38M
164.65%26.15M
Financing cash flow
Cash flow from continuing financing activities
-99.14%887K
-86.31%192K
172.73%8K
-99.67%337K
69.90%350K
389.44%102.96M
103.19%1.4M
-102.99%-11K
22,781.94%101.37M
-98.95%206K
Net common stock issuance
--0
--0
--0
----
----
413.26%99.61M
--0
---392K
--100M
--0
Proceeds from stock option exercised by employees
-73.57%887K
-86.31%192K
-97.90%8K
-75.35%337K
69.90%350K
105.89%3.36M
103.19%1.4M
3.53%381K
208.58%1.37M
59.69%206K
Cash from discontinued financing activities
Financing cash flow
-99.14%887K
-86.31%192K
172.73%8K
-99.67%337K
69.90%350K
389.44%102.96M
103.19%1.4M
-102.99%-11K
22,781.94%101.37M
-98.95%206K
Net cash flow
Beginning cash position
46.97%105.16M
18.58%97.24M
-59.60%76.43M
-0.83%71.79M
46.97%105.16M
45.71%71.55M
46.87%82M
126.07%189.2M
-68.74%72.39M
45.71%71.55M
Current changes in cash
-132.18%-10.82M
-112.49%-2.89M
119.41%20.8M
-96.02%4.65M
-4,101.68%-33.37M
49.74%33.61M
47.34%23.16M
-284.78%-107.2M
178.98%116.82M
-99.54%834K
End cash Position
-10.29%94.34M
-10.29%94.34M
18.58%97.24M
-59.60%76.43M
-0.83%71.79M
46.97%105.16M
46.97%105.16M
46.87%82M
126.07%189.2M
-68.74%72.39M
Free cash flow
-189.73%-129.55M
0.76%-32M
-13.00%-28.14M
-176.74%-29.76M
-50.44%-39.65M
-133.32%-44.72M
-546.22%-32.24M
3.99%-24.91M
205.94%38.79M
-113.07%-26.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -209.24%-128.51M-1.89%-32.2M-16.68%-28.31M-174.03%-29.49M-50.90%-38.51M-129.73%-41.56M-687.57%-31.61M0.92%-24.27M213.51%39.83M-112.55%-25.52M
Net income from continuing operations -319.04%-143.75M-3,562.78%-39.16M-214.52%-44.13M-178.32%-43.1M-173.84%-17.35M1,081.69%65.63M111.85%1.13M-139.57%-14.03M312.25%55.03M452.05%23.5M
Depreciation and amortization 8.56%4.1M-10.69%886K31.27%1.23M13.63%1.03M1.28%946K32.81%3.77M34.78%992K12.35%937K24.66%910K72.64%934K
Change In working capital 95.96%-4.8M106.54%2.35M179.68%10.21M145.99%8.49M49.94%-25.85M-187.19%-118.85M-1,316.42%-35.92M79.44%-12.82M-63.14%-18.47M-124.95%-51.65M
-Change in receivables 13.88%2.5M101.76%19K-100.32%-16K-98.76%864K102.28%1.64M137.39%2.2M-26.26%-1.08M495.86%5.07M2,635.61%69.84M-1,037.62%-71.64M
-Change in prepaid assets 272.23%7.64M150.59%1.5M393.32%3.73M262.95%4.68M-184.81%-2.27M-151.46%-4.44M-123.75%-2.97M91.39%-1.27M-143.88%-2.87M-38.23%2.68M
-Change in payables and accrued expense 445.90%2.28M-21.98%653K555.03%5.67M414.69%3.19M-437.44%-7.23M-113.08%-658K-90.02%837K114.60%865K51.04%-1.01M-129.00%-1.35M
-Change in other current assets -15.48%10.88M-43.37%1.76M37.53%3.6M-39.35%2.78M7.11%2.74M2,922.54%12.88M201.26%3.12M43.47%2.61M59.77%4.59M148.29%2.56M
-Change in other current liabilities 8.29%-8.28M30.33%-1.47M25.12%-2.34M-13.32%-2.25M-22.91%-2.21M23.93%-9.02M-350.54%-2.11M20.98%-3.13M70.72%-1.99M7.79%-1.8M
-Change in other working capital 83.45%-19.83M99.64%-122K97.53%-419K99.12%-770K-203.46%-18.51M-185.59%-119.81M-77.73%-33.72M55.60%-16.97M-503.22%-87.02M-91.54%17.9M
Cash from discontinued investing activities
Operating cash flow -209.24%-128.51M-1.89%-32.2M-16.68%-28.31M-174.03%-29.49M-50.90%-38.51M-129.73%-41.56M-687.57%-31.61M0.92%-24.27M213.51%39.83M-112.55%-25.52M
Investing cash flow
Cash flow from continuing investing activities 520.20%116.81M-45.43%29.12M159.22%49.11M238.61%33.8M-81.71%4.78M79.91%-27.8M180.23%53.37M-2,119.08%-82.93M78.47%-24.38M164.65%26.15M
Net PPE purchase and sale 67.04%-1.04M132.60%207K126.76%171K73.71%-275K-36.52%-1.14M43.75%-3.16M34.94%-635K55.87%-639K31.27%-1.05M49.76%-838K
Net investment purchase and sale 578.28%117.85M-46.46%28.91M159.47%48.94M246.00%34.07M-78.04%5.93M81.44%-24.64M169.74%54M-3,494.93%-82.29M79.11%-23.34M169.59%26.99M
Cash from discontinued investing activities
Investing cash flow 520.20%116.81M-45.43%29.12M159.22%49.11M238.61%33.8M-81.71%4.78M79.91%-27.8M180.23%53.37M-2,119.08%-82.93M78.47%-24.38M164.65%26.15M
Financing cash flow
Cash flow from continuing financing activities -99.14%887K-86.31%192K172.73%8K-99.67%337K69.90%350K389.44%102.96M103.19%1.4M-102.99%-11K22,781.94%101.37M-98.95%206K
Net common stock issuance --0--0--0--------413.26%99.61M--0---392K--100M--0
Proceeds from stock option exercised by employees -73.57%887K-86.31%192K-97.90%8K-75.35%337K69.90%350K105.89%3.36M103.19%1.4M3.53%381K208.58%1.37M59.69%206K
Cash from discontinued financing activities
Financing cash flow -99.14%887K-86.31%192K172.73%8K-99.67%337K69.90%350K389.44%102.96M103.19%1.4M-102.99%-11K22,781.94%101.37M-98.95%206K
Net cash flow
Beginning cash position 46.97%105.16M18.58%97.24M-59.60%76.43M-0.83%71.79M46.97%105.16M45.71%71.55M46.87%82M126.07%189.2M-68.74%72.39M45.71%71.55M
Current changes in cash -132.18%-10.82M-112.49%-2.89M119.41%20.8M-96.02%4.65M-4,101.68%-33.37M49.74%33.61M47.34%23.16M-284.78%-107.2M178.98%116.82M-99.54%834K
End cash Position -10.29%94.34M-10.29%94.34M18.58%97.24M-59.60%76.43M-0.83%71.79M46.97%105.16M46.97%105.16M46.87%82M126.07%189.2M-68.74%72.39M
Free cash flow -189.73%-129.55M0.76%-32M-13.00%-28.14M-176.74%-29.76M-50.44%-39.65M-133.32%-44.72M-546.22%-32.24M3.99%-24.91M205.94%38.79M-113.07%-26.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -